Related Experiment Videos
The effect of cytotoxic agents on the primary immune response to Listeria monocytogenes
Abstract:
Four drugs, representing four different categories of cytotoxic agents, were studied for their effect on the immune response to Listeria infection in mice. The development of the host's immune response is revealed by a progressive change in the slope of the bacterial growth curve in spleen and liver. It has its onset at 24 hr in untreated mice, but in the presence of effective immunosuppression the organism multiples uninterruptedly until the animal dies from overwhelming infection. When administered as single injections at the time of infection, cyclophosphamide, vinblastine, and azathioprine all produced an effective immunosuppression, characterized by continuous bacterial multiplication. Methotrexate was also immunosuppressive, but unlike the others its effects were reversible. They could be sustained, however, by further treatment. Studies of the time-response relationship indicated that cyclophosphamide was highly active over a broad time-span ranging from 2 days before infection to 4 days after infection. Vinblastine on the other hand was maximally active when given on the day of infection, while methotrexate had its greatest effect when given 48 hr after infection. These differences indicate that these three drugs act on different cell populations involved in the host's immune response. The effects observed have been discussed in relation to what is known of the modes of action of the drugs tested. An observation of interest was the phenomenon of enhanced immunity in animals treated with cyclophosphamide or vinblastine 7-11 days before, and with methotrexate 4 days before infection; reactive hyperplasia of lymphoid tissue following withdrawal of drug was again advanced as an explanation for the occurrence of this paradoxical effect. The experimental model employed is simple, requiring only routine bacteriological facilities and minimal equipment. It seems to offer a useful means of assessing the immunosuppressive activity of drugs and of determining the time-course of their action; it could also be of value in the screening of anticancer agents.
Insights
Four cytotoxic drugs were tested for their impact on the immune response to Listeria infection in mice. Cyclophosphamide, vinblastine, and azathioprine caused immunosuppression, while methotrexate
Area of Science:
- Immunology
- Pharmacology
- Microbiology
Background:
- Cytotoxic agents are used in cancer therapy and can impact the immune system.
- Listeria infection in mice is a model for studying host immune responses.
- Understanding drug effects on immunity is crucial for therapeutic applications.
Purpose of the Study:
- To investigate the immunosuppressive effects of four different cytotoxic drugs on the murine immune response to Listeria infection.
- To characterize the time-course and reversibility of drug-induced immunosuppression.
- To explore potential applications of the experimental model in drug screening.
Main Methods:
- Mice were infected with Listeria and treated with single injections of cyclophosphamide, vinblastine, azathioprine, or methotrexate.
- Bacterial growth curves in spleen and liver were used to assess the host immune response.
- Time-response relationships were studied by varying drug administration timing relative to infection.
Main Results:
- Cyclophosphamide, vinblastine, and azathioprine induced sustained immunosuppression, characterized by continuous bacterial multiplication.
- Methotrexate exhibited reversible immunosuppression, which could be maintained with further treatment.
- Optimal drug efficacy varied with timing: cyclophosphamide (2 days before to 4 days after infection), vinblastine (day of infection), and methotrexate (48 hours after infection).
- Enhanced immunity was observed with pre-infection treatment, possibly due to lymphoid tissue hyperplasia.
Conclusions:
- The four cytotoxic drugs differentially affect the immune response to Listeria infection in mice.
- Drug timing is critical for efficacy, suggesting distinct cellular targets for each agent.
- The experimental model is a valuable tool for assessing drug immunosuppressive activity and screening anticancer agents.